Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.
Biotechnol Bioeng. 2023 Oct;120(10):2917-2924. doi: 10.1002/bit.28473. Epub 2023 Jun 20.
Cell-based manufacturing processes have occasionally been exposed to adventitious viruses, leading to manufacturing interruptions and unstable supply situations. The rapid progress of advanced therapy medicinal products needs innovative approaches to avoid any unwelcome reminder of the universal presence of viruses. Here, we investigated upstream virus filtration as a clearance step for any product too complex for downstream interventions. Culture media virus filtration was investigated with respect to virus clearance capacities under extreme conditions such as high process feed loading (up to ~19,000 L/m²), long duration (up to 34 days), and multiple process interruptions (up to 21 h). The small nonenveloped Minute virus of mice was used as relevant target virus, and as worse-case challenge for the investigated virus filters with a stipulated pore-size of about 20 nm. Certain filters-especially of the newer second generation-were capable of effective virus clearance despite the harsh regimen they were subjected to. The biochemical parameters for un-spiked control runs showed the filters to have no measurable impact on the composition of the culture media. Based on these findings, this technology seems to be quite feasible for large volume premanufacturing process culture media preparations.
基于细胞的制造工艺偶尔会暴露于外来病毒,导致生产中断和供应不稳定。先进治疗药物产品的快速发展需要创新的方法来避免任何对无处不在的病毒的不愉快提醒。在这里,我们研究了上游病毒过滤作为一种清除步骤,以避免任何过于复杂的产品需要下游干预。研究了培养基病毒过滤在极端条件下的病毒清除能力,例如高过程进料负载(高达约 19000L/m²)、长时间(长达 34 天)和多次过程中断(长达 21 小时)。小无包膜的小鼠微小病毒被用作相关的靶病毒,并作为规定孔径约为 20nm 的被调查病毒过滤器的最坏情况挑战。某些过滤器-特别是较新的第二代-尽管受到苛刻的方案处理,但仍能够有效地清除病毒。未经污染控制运行的生化参数表明,过滤器对培养基的组成没有可测量的影响。基于这些发现,这项技术似乎非常适用于大容量生产前工艺培养基的制备。